Pentobarbital will lessen the extent or result of buprenorphine buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. pentobarbital will lower the extent or impact of disopyramide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified. Avoid coadministration of ganaxolone with average or solid CYP3A4 inducers. If coadmin... https://friedrichs276qhp3.bloggadores.com/profile